FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2523413541> ?p ?o ?g. }

• W2523413541 endingPage "69" @default.
• W2523413541 startingPage "59" @default.
• W2523413541 abstract "<h3>Background:</h3> The heterogeneity of Alzheimer disease requires the development of multitarget drugs for treating the symptoms of the disease and its progression. Both cholinergic and monoamine oxidase dysfunctions are involved in the pathological process. Thus, we hypothesized that the development of therapies focused on these targets might be effective. We have developed and assessed a new product, coded ASS234, a multipotent acetyl and butyrylcholinesterase/monoamine oxidase A–B inhibitor with a potent inhibitory effect on amyloid-β aggregation as well as antioxidant and antiapoptotic properties. But there is a need to reliably correlate in vitro and in vivo drug release data. <h3>Methods:</h3> We examined the effect of ASS234 on cognition in healthy adult C57BL/6J mice in a model of scopolamine-induced cognitive impairment that often accompanies normal and pathological aging. Also, in a characterized transgenic APPswe/PS1ΔE9 mouse model of Alzheimer disease, we examined the effects of short-term ASS234 treatment on plaque deposition and gliosis using immunohistochemistry. Toxicology of ASS234 was assessed using a quantitative high-throughput in vitro cytotoxicity screening assay following the MTT assay method in HepG2 liver cells. <h3>Results:</h3> In vivo, ASS234 significantly decreased scopolamine-induced learning deficits in C57BL/6J mice. Also, reduction of amyloid plaque burden and gliosis in the cortex and hippocampus was assessed. In vitro, ASS234 exhibited lesser toxicity than donepezil and tacrine. <h3>Limitations:</h3> The study was conducted in male mice only. Although the Alzheimer disease model does not recapitulate all features of the human disease, it exhibits progressive monoaminergic neurodegeneration. <h3>Conclusion:</h3> ASS234 is a promising alternative drug of choice to treat the cognitive decline and neurodegeneration underlying Alzheimer disease." @default.
• W2523413541 created "2016-09-30" @default.
• W2523413541 creator A5002065879 @default.
• W2523413541 creator A5012744240 @default.
• W2523413541 creator A5017542552 @default.
• W2523413541 creator A5018104052 @default.
• W2523413541 creator A5028704915 @default.
• W2523413541 creator A5061878808 @default.
• W2523413541 creator A5070914067 @default.
• W2523413541 creator A5072085025 @default.
• W2523413541 creator A5082905681 @default.
• W2523413541 creator A5084243261 @default.
• W2523413541 date "2017-01-01" @default.
• W2523413541 modified "2023-10-02" @default.
• W2523413541 title "The proof-of-concept of ASS234: Peripherally administered ASS234 enters the central nervous system and reduces pathology in a male mouse model of Alzheimer disease" @default.
• W2523413541 cites W1428351561 @default.
• W2523413541 cites W1530682407 @default.
• W2523413541 cites W1551854265 @default.
• W2523413541 cites W1557592540 @default.
• W2523413541 cites W1565624092 @default.
• W2523413541 cites W1580458257 @default.
• W2523413541 cites W1629179716 @default.
• W2523413541 cites W1743419595 @default.
• W2523413541 cites W1825546964 @default.
• W2523413541 cites W1970281475 @default.
• W2523413541 cites W1971238455 @default.
• W2523413541 cites W1975141413 @default.
• W2523413541 cites W1978991736 @default.
• W2523413541 cites W1981546185 @default.
• W2523413541 cites W1981581272 @default.
• W2523413541 cites W1981654394 @default.
• W2523413541 cites W1985940694 @default.
• W2523413541 cites W1991286971 @default.
• W2523413541 cites W1992326577 @default.
• W2523413541 cites W1994087800 @default.
• W2523413541 cites W1996241541 @default.
• W2523413541 cites W1997967956 @default.
• W2523413541 cites W2000837493 @default.
• W2523413541 cites W2001405361 @default.
• W2523413541 cites W2003881435 @default.
• W2523413541 cites W2003966687 @default.
• W2523413541 cites W2010683624 @default.
• W2523413541 cites W2017645489 @default.
• W2523413541 cites W2024221433 @default.
• W2523413541 cites W2025223727 @default.
• W2523413541 cites W2028902657 @default.
• W2523413541 cites W2030320815 @default.
• W2523413541 cites W2033354312 @default.
• W2523413541 cites W2038289033 @default.
• W2523413541 cites W2042069812 @default.
• W2523413541 cites W2042677967 @default.
• W2523413541 cites W2044354004 @default.
• W2523413541 cites W2049884294 @default.
• W2523413541 cites W2052526935 @default.
• W2523413541 cites W2056716542 @default.
• W2523413541 cites W2061764592 @default.
• W2523413541 cites W2079313884 @default.
• W2523413541 cites W2082429191 @default.
• W2523413541 cites W2086602093 @default.
• W2523413541 cites W2087880903 @default.
• W2523413541 cites W2103440561 @default.
• W2523413541 cites W2107013935 @default.
• W2523413541 cites W2118921211 @default.
• W2523413541 cites W2131697773 @default.
• W2523413541 cites W2138645881 @default.
• W2523413541 cites W2145810295 @default.
• W2523413541 cites W2146158590 @default.
• W2523413541 cites W2146217163 @default.
• W2523413541 cites W2153290611 @default.
• W2523413541 cites W2165292497 @default.
• W2523413541 cites W2166804136 @default.
• W2523413541 cites W2179678281 @default.
• W2523413541 doi "https://doi.org/10.1503/jpn.150209" @default.
• W2523413541 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5373713" @default.
• W2523413541 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27636528" @default.
• W2523413541 hasPublicationYear "2017" @default.
• W2523413541 type Work @default.
• W2523413541 sameAs 2523413541 @default.
• W2523413541 citedByCount "19" @default.
• W2523413541 countsByYear W25234135412016 @default.
• W2523413541 countsByYear W25234135412017 @default.
• W2523413541 countsByYear W25234135412018 @default.
• W2523413541 countsByYear W25234135412019 @default.
• W2523413541 countsByYear W25234135412020 @default.
• W2523413541 countsByYear W25234135412021 @default.
• W2523413541 countsByYear W25234135412022 @default.
• W2523413541 countsByYear W25234135412023 @default.
• W2523413541 crossrefType "journal-article" @default.
• W2523413541 hasAuthorship W2523413541A5002065879 @default.
• W2523413541 hasAuthorship W2523413541A5012744240 @default.
• W2523413541 hasAuthorship W2523413541A5017542552 @default.
• W2523413541 hasAuthorship W2523413541A5018104052 @default.
• W2523413541 hasAuthorship W2523413541A5028704915 @default.
• W2523413541 hasAuthorship W2523413541A5061878808 @default.
• W2523413541 hasAuthorship W2523413541A5070914067 @default.
• W2523413541 hasAuthorship W2523413541A5072085025 @default.
• W2523413541 hasAuthorship W2523413541A5082905681 @default.
• W2523413541 hasAuthorship W2523413541A5084243261 @default.

• next